Neobiomics AB

Active
559072-2186Limited company (AB)Registered 2016SOLNA

Key figures

15 834 000 kr+38,4%
Revenue 2024
+33,6%
Average annual growth 2022–2024
05 m10 m15 m20 m202220232024

Key figures

2024

Summary: Neobiomics AB

What kind of company is it?

Neobiomics AB (org. no. 559072-2186) is a limited company (AB). The company was registered in 2016 and has existed for 10 years. Registered seat: Solna. Industry according to Statistics Sweden: other research and experimental development on natural sciences and engineering (SNI 72109).

How is the company doing financially?

Net sales in financial year 2024 were 15 834 000 kr, up 38,4 % on the previous year (11 440 000 kr). From 2022 to 2024, net sales grew by an average of 33,6 % per year. Net profit for 2024 was 3 815 866 kr (24,1 % of net sales). The company was profitable in 2 of the 3 reported financial years. Employees in financial year 2024: 9 (previous year: 7). Net sales per employee were 1 759 333 kr. At the end of financial year 2024, total assets were 10 378 733 kr and equity 9 281 431 kr (equity ratio 89,4 %).

Where does the data come from and how up to date is it?

Company details and digitally filed annual reports come from the open data of the Swedish Companies Registration Office (Bolagsverket) and the industry code from Statistics Sweden (CC BY 2.5 SE); bolagsprofil.se updates them daily. The latest annual report is signed by 5 people. Data as of 2026-11-16. Changes, averages and ratios are calculated by bolagsprofil.se from open data and are not an official assessment.

Summary of annual reports2022–2024
202220232024
Sales revenue8 876 00011 440 00015 834 000
Profit for the reporting year935 842−56 6743 815 866
Retained earnings of previous periods———
Total assets8 792 6748 888 63510 378 733
Total liabilities3 252 4353 405 0701 097 302
Total equity5 540 2395 483 5659 281 431
Employees679

A dash (—) means the report has not been filed or the line is not reported; 0 is a zero stated in the report.